scispace - formally typeset
H

Hanghang Liu

Researcher at Soochow University (Suzhou)

Publications -  31
Citations -  1157

Hanghang Liu is an academic researcher from Soochow University (Suzhou). The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 14, co-authored 17 publications receiving 520 citations.

Papers
More filters
Journal ArticleDOI

Boosting H2O2‐Guided Chemodynamic Therapy of Cancer by Enhancing Reaction Kinetics through Versatile Biomimetic Fenton Nanocatalysts and the Second Near‐Infrared Light Irradiation

TL;DR: The CDT treatment of breast cancer using biomimetic CS‐GOD@CM nanocatalysts, which are rationally designed to significantly boost the Fenton reaction through improvement of H2O2 concentration within tumors, and application of the second near‐infrared (NIR‐II) light irradiation at the maximum concentration.
Journal ArticleDOI

Boosting the Radiosensitizing and Photothermal Performance of Cu2–xSe Nanocrystals for Synergetic Radiophotothermal Therapy of Orthotopic Breast Cancer

TL;DR: It is reported that dumbbell-shaped heterogeneous copper selenide-gold nanocrystals can serve as an efficient radiosensitizer for enhanced radiotherapy and exhibit an enhanced photothermal conversion efficiency, due to the synergetic interactions of localized surface plasmon resonance.
Journal ArticleDOI

Engineering NIR-IIb fluorescence of Er-based lanthanide nanoparticles for through-skull targeted imaging and imaging-guided surgery of orthotopic glioma

TL;DR: The capability of the strong second near-infrared-IIb (NIR IIb, 1500−1700 nm) fluorescence from Er-based lanthanide nanoparticles in imaging-guided surgery of orthotopic glioma is reported and the highest tumor-to-background ratio ever reported is obtained.
Journal ArticleDOI

Second near-infrared photodynamic therapy and chemotherapy of orthotopic malignant glioblastoma with ultra-small Cu2-xSe nanoparticles.

TL;DR: The results show that the tumor growth can be significantly suppressed and the great potential of drug-loaded ultra-small Cu2-xSe NPs as a promising therapeutic agent for the treatment of orthotopic malignant glioblastoma is demonstrated.
Journal ArticleDOI

Boosting often overlooked long wavelength emissions of rare-earth nanoparticles for NIR-II fluorescence imaging of orthotopic glioblastoma

TL;DR: This study delivers highly bright nanoparticles into the brain by using focused ultrasound to temporarily open the blood-brain barrier, and then detects the orthotopic glioblastoma by fluorescence imaging at 1340 nm, demonstrating great potential of focused ultrasound based technology in delivering nanotheranostic agents.